INVITATION TO 3RD WORLD CONGRESS ON DRUG DISCOVERY AND DEVELOPMENT - 2019, MUMBAI, INDIA

Arjyopa Healthcare and Raytheon Healthcare welcomes you to attend the 3rd World Congress on Drug Discovery and Development- 2019 during November 20 - 21, 2019 at Mumbai, India. We cordially invite all the participants interested in sharing their knowledge and research in the arena of Drug Development and Research.

The 3rd World Congress on Drug Discovery and Development - 2019 maximizes the opportunity to interact with and learn from your peers from across the country and across the globe it held with the discussions of Pharmaceutical Research & Development, Translational Medicine, Regenerative Medicine, Enabling Technologies, Structural Biology, Drug Delivery & Targeting, Antiinfectives, Biologics, CNS Drug Discovery & Therapy, Diabetes and Obesity Drug Discovery & Therapy, Women's Health Drug Discovery & Therapy, Drug Discovery in Preclinical Research, Cardiovascular Drug Discovery & Therapy, Oncology, Process Chemistry and Drug Manufacturing, Pulmonary Drug Discovery & Therapy, Recent Advances in Patient Treatment and Care, Inflammation and Immunology, Innovative Drug Discovery and Nanotechnology, Pharmaceutical Biotechnology, Proteomics & Bioinformatics, Pharmacogenomics, Protein and Peptide Sciences, Drug Metabolism, Hot Topics in Medicinal Chemistry, Medical Imaging, Hot Topics in HIV Research, In-silico Drug Design and in-silico screening, Combinatorial Chemistry, High-throughput Screening & Laboratory automation, Hot Topics in Drug Targets, Hot Topics in Natural Products, Stereoselective Synthesis of Bioactive Compounds, Recent Advances in Spectroscopy, Academic CRO/Industrial collaborations in drug discovery.

The scientific program will feature live workshops, interactive education sessions, B2B meetings, round-table discussions apart from the conventional plenary sessions, featured symposia, break out sessions and oral presentation sessions for abstracts and challenging cases.In addition, 3rd World Congress on Drug Discovery and Development - 2019 will feature live cases and interventional courses in an interactive format throughout the conference. Our endeavor is to provide a stimulating and thought provoking scientific program. We sincerely hope that the blend of pleasant weather, warm hospitality and revitalizing social evenings will make the scientific environment richer.

We look forward to the honor of welcoming you in Mumbai, India.

With Warm Regards

Partha J. Das

Convenor, Organizing Team

CEO and Co-Founder, Raytheon Healthcare

Aruna Das

Convenor, Organizing Team

CEO and Co-Founder, Arjyopa Healthcare

Chairman Message

On behalf of the organizing committee, it is a great privilege to extend my invitation to all of you to the 3rd World Congress on Drug Discovery and Development - 2019 to be held on 20th and 21st of November 2019 at Mumbai. The theme for this year’s conference is “Advances in Drug Discovery and Development”. The meeting has been conceptualized as an international health care summit that will bring under a common umbrella, two major topics: cancer, and drug development and discovery. The meeting will provide a unique platform for scientists across geographies to share their insights on emerging challenges in cancer therapy, management, and novel therapeutic approaches. In a rapidly changing clinical landscape, cancer emerges as a phenotypically diverse and heterogeneous ailment, where tumor microenvironment mimicking global ecosystem limits the success of existing treatment paradigms. On one hand, drug discovery and development in an era of personalized medicine is affected owing to lack of proper preclinical de-risking tools. Further compounding this diminishing return, there is a shortage of effective therapeutics with low toxicities and affordable prices, which together hinder the rationalization of therapy combinations in the personalized settings. I believe that the upcoming summit will address these issues and help us to bridge the gap between different stakeholders while enabling to work towards a consensus statement.

We are particularly expecting active participation of young investigators and research students, besides established academic, industry and business leaders, for making the conference a truly stimulating event.

The scientific program this year is intended to cover a spectrum of topics such as cancer awareness, social and economic challenges, complementary medicines, tumor microenvironment, biomarkers, preclinical disease models, emerging treatment paradigms like immunotherapy, precision therapy, and challenges pertaining to drug discovery, development, and transitional research.

The two-day long conference has been scheduled to have sessions covering key note address, plenary lectures, invited and oral presentations. This year the organizer has introduced two awards: Renato Dulbecco Memorial Award and Edward Keenedy Award that will be conferred to the best senior and young scientists of the conference, respectively.

Mumbai, known as a leading knowledge hub with pleasant climate, is a perfect place to meet and discuss innovation, challenges and opportunities to promote science.

I am looking forward to your valued participation and knowledge sharing in this conference.

With Warm Regards

Padmashri Dr. Ramakant Krishnaji Deshpande

Director,

Asian Cancer Institute

Co-Chairman Message

After a successful conference of 2nd World Congress on Drug Discovery and Development – 2018, Bangalore, I would cordially invite participants from all over the world to attend "3rd World Congress on Drug Discovery and Development - 2019 slated on November 20 – 21, 2019 at Mumbai, India. This 3rd Drug Discovery Conference includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs.

3rd World Congress on Drug Discovery and Development - 2019 covers various aspects of Bio-Pharmaceutics, Pharmaceutical Chemistry, Drug Targeting and Design, Pharmacokinetics and Pharmacodynamics in Drugs, Pharmaceutical Formulation, Pharmaceutical Manufacturing, Pharmaceutical Nanotechnology, Novel Drug Delivery Systems, Smart Drug Delivery Systems, Nanomedicine and Biomedical Applications, Biomaterials in Drug Delivery, Vaccine Drug Delivery Systems, Medical Devices for Drug Delivery, Biologics & Biosimilars, Pharmaceutical Analysis, Pharmaceutical Process Validation, Pharmaceutical Packaging, Clinical Trials and Clinical Research, Pharmacogenetics and Genomics, Regulatory Affairs and Intellectual Property Rights, Industrial and Physical Pharmacy, Clinical and Hospital Pharmacy, Pharmacovigilance and Drug Safety, Pharmacy Education and Practice

The Excellent Program and Networking at this meeting in the historic city of Mumbai will provide new insight and opportunities for new lasting collaborations for all attendees.

Hope to see you at Mumbai, Thank You.

With Warm Regards

Prof. Shubhada V. Chiplunkar

Director,

Advanced Centre for Treatment, Research & Education in Cancer (ACTREC)

SUPPORTING ORGANISATION

PAST SPONSORS